Can a simple chat with your GP after cancer treatment keep you out of the hospital?
NCT ID NCT02857400
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a planned meeting between a hospitalized cancer patient, their family doctor, and a specialist could reduce unplanned hospital visits. 667 adults with metastatic solid tumors were randomly assigned to either the standard discharge process or this organized 'return home' consultation. The goal was to see if better communication at discharge leads to fewer emergency visits and hospital readmissions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that a simple, organized discharge meeting with a GP reduces unplanned hospital visits and improves patient satisfaction.
- What could go wrong
- This is a completed study, but it only tested a communication process, not a new drug or treatment. The results may not apply to all cancer types or healthcare systems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Auch
Auch, 32008, France
-
Hopital Rangueil
Toulouse, 31 059, France
-
Institut Claudius Regaud
Toulouse, 31059, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tissue analysis may guide personalized cancer therapy
- Can a new drug combo shrink Hard-to-Treat salivary gland tumors?
- Blood test vs. scalpel: could liquid biopsy replace tissue biopsies for cancer monitoring?
- Can a new nucleotide analogue boost cancer treatment?
- Zapping resistant tumors with precision radiation may extend the life of current cancer therapy
- Can two targeted drugs boost chemo against a rare Bile-Duct cancer?